Description de l'entreprise
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, the company offers the broadest portfolio of products to enhance sight and improve people’s lives. Its Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. More than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
Conseil d'administration & Conseil de surveillance
| PDG |
| David Endicott |
| Conseil d'administration |
| Tim Stonesifer, Ian Bell, Laurent Attias, Rajkumar Narayanan, Sergio Duplan, Sue-Jean Lin |
| Conseil de surveillance |
| F. Michael Ball, Arthur Cummings, D. Keith Grossman, David J. Endicott, Dieter Spälti, Ines Pöschel, Karen May, Lynn Bleil, Scott Maw, Thomas Glanzmann, Raquel C. Bono |
Données de l'entreprise
| Nom: |
Alcon Inc. |
| Adresse: |
Chemin de Blandonnet 8,CH-1214 Vernier, Geneva |
| Téléphone: |
+41-589-112-110 |
| Fax: |
- |
| Courriel: |
investor.relations@alcon.com
|
| Internet: |
https://www.alcon.com |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
98.64% |
| IPO date: |
09/04/2019 |
